Reddit Posts
large oversold ready to go for the moon
The penny stocks that are buys right now in the biopharmaceutical industry
Mentions
Sounded promising so I did a little digging. The results of a recent comparison between this drug and the current treatment is that this drug is significantly less effective. The only positives are slightly lower adverse effects and quicker treatment plan. It will never become the main treatment for smoking cessation but it might make money from people worried about the adverse effects of the main drug currently being used. I also haven’t quite figured out what the deal with the patents are on this one. It’s a naturally derived compound and it looks like ACHV holds a few patents but for what purpose I’m still not sure. I would be careful with this one. I’m going to put it on my watchlist but keep my money in other investments. https://pubmed.ncbi.nlm.nih.gov/37291049/#:~:text=Conclusions:%20This%20randomized%20non%2Dinferiority,treatments%20for%20health%20policy%20considerations.
ACHV buy and look again end of year
Is ACHV done or more room do u think?
Strong disagree. The internet (and Reddit) is just like life, there's plenty of people with good and plenty with bad advice. The people with good advice have good data and are happy to provide it. I've only been actively trading for about 3 years, but the conversations about stocks that I've found on Reddit have been really helpful. RKLB, ASTS, ACHV, HIMS... I've gotten some huge gains from Reddit convos because I have only acted on the one's that have good data.
AdmiralDonutz's stock pick of the day is **ACHV**, Achieve Life Sciences. These guys are a biotech disruptor outta Seattle developing a next-gen smoking cessation drug called cytisinicline. Picture this: a pill so effective it'll make the Marlboro Man throw his cowboy hat in the trash and cry into a nicotine patch. The FDA's watching, Wall Street’s drooling, and once approval hits, it's Lambo season, baby.
Hopped on ACHV at least for now. Reports predicting good gains short and long
RJ is also a book running manager of the $45MM offering from several weeks ago. In some ways they’re incentivized to have one of their analysts hype the stock and get buyers to push the price back to its offering of $3. Bit of a sleazy tactic. ACHV could jump on positive news from FDA later this summer, but expect dilution in the future.
So its a short term or a long term investment for ACHV ?
Make sure ACHV is on your watchlist tomorrow morning -- there’s real potential for it to take off.
Appreciate the transparency. Been watching $ACHV myself - volume spike caught my eye last week. Let’s see if it follows through
Yes SORA and ACHV very likely movement this week as long as the volume is there.
Interesting picks — ACHV and SORA have been on my radar too. Appreciate the transparency and detail behind the signals. Curious to see how this week plays out.
Yes. Haven’t sold my stocks or warrants. My hunch is they are working with the fda to avoid another study, and will go straight to submitting a nda. This administration has said they want to speed up the approval process. But we shall see. Im also in ACHV which is on the verge of submitting a nda for a new smoking/vaping cessation drug.
ACHV (Achieve Life Sciences) is scheduled to submit an NDA in june * This post is for informational purposes only and does not constitute investment advice. Always conduct your own research before making investment decisions. I hold shares in ACHV.
I wonder if it's true that ACHV has patented specific dosing regimens, but not the drug Cytisinicline itself, which has been used for decades.
Check out ACHV. It may be worth considering, as the CEO mentioned an NDA submission in Q2 2025, and the company completed the half-year ORCA-OL trial with no safety concerns identified *This is just my personal opinion, not financial advice. Please do your own research before investing
Recently I came across ACHV. It might be worth checking out. *Not a recommendation, just my opinion, do your own research
A more better option would be ACHV, already finished phase 3 and the results are pretty good, submission for fda approval in early 2025. Already got some good signals from FDA. They also received a debt financing till the NDA application is submitted and the result is posted. The market is smoking cessation, and the only compatitor is pfizer(**CHANTIX**). However, chantix has lead to nausea in many users leading to quitting the usage and eventually the user takes back smoking, also the course is expensive and is always in issue of supply chain and hard to find. ACHV’s cytisinicline not only shows promising efficacy but also boasts a better safety profile compared to Chantix. The recent Breakthrough Therapy designation for vaping cessation further positions them well in a growing market.
Yeah we do… just don’t want to face the loss… I’ve been holding a major loss in ACHV shares for six years… I am highly regarded
Any thoughts on ACHV stock. Down about half and trying to figure out to dump or hold??
Bullish on $BEEM and $ACHV
$ACHV and $BEEM are the moves today
Closely watching BEEM and ACHV today
Has anyone been watching the ACHV chart?
At the peak of covid I would check this platform every morning and just grab a few suggestions and send it. (Urban One - 300 shares at $2.67. Its now at $5.59) (ACHV - 100 shares at .78. It’s now at $8.29) (NTEC - 100 shares at .36. It’s now at $9.63) Now of course I sold alll of these bastards before they matured, I was young and didn’t know… now I’m older and know that I definitely don’t know. 🌚
$ACHV for a solid P3 phased bio
NCNA, SLNO, NVNO, OBSV, ACHV, MBRX, NVCN all are waiting for some good news. I am waiting which will be first.
$ACHV has a market cap of $70m, $40m in cash, no debt. Low float stock. Smoking cessation drug in phase 3 trials. Full enrollment press release expected by end of March. Much better side effect profile than Chantix which has $1b in sales! Currently $12 with high short interest and analyst price targets around $50!
$ACHV has a market cap of $70m, $40m in cash, no debt. Low float stock. Smoking cessation drug in phase 3 trials. Full enrollment press release expected by end of March. Much better side effect profile than Chantix which has $1b in sales! Currently $12 with high short interest and analyst price targets around $50!
Love your dd, top job my friend! I have also just bought £400 worth of ACHV as I can see it being hugeee when they get the all clear to start selling it in the USA. When do you think they will get approved if they do and what do you think the chances of them getting turned down are? I’d love to hear other people’s thoughts as not many people know about this gem.
Sell before it goes down. I unfortunately got caught up in the whole $BB meme, I know it will go up but it wasn’t worth it for me to hold a year just to break even so I sold at 3k loss then reinvested from the BB sales in ACHV and have made everything back in a week! Good luck